Added Value of Extragenital Sexually Transmitted Infection Testing in "IWantTheKit" Program Users
The 2021 Centers for Disease Control and Prevention sexually transmitted infection treatment guidelines recommend extragenital testing for gonorrhea and chlamydia in men who have sex with men and for women based on reported behaviors and exposures. The "IWantTheKit (IWTK)" program is a fre...
Uloženo v:
| Vydáno v: | Sexually transmitted diseases Ročník 50; číslo 3; s. 138 |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.03.2023
|
| Témata: | |
| ISSN: | 1537-4521, 1537-4521 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The 2021 Centers for Disease Control and Prevention sexually transmitted infection treatment guidelines recommend extragenital testing for gonorrhea and chlamydia in men who have sex with men and for women based on reported behaviors and exposures. The "IWantTheKit (IWTK)" program is a free online platform for specimen self-collection and mail-in for combined chlamydia/gonorrhea testing. We sought to assess the additional diagnostic value of extragenital testing compared with genital testing only for chlamydia/gonorrhea and determine factors associated with a positive extragenital test result among IWTK users.
From August 2013 to January 2022, 7612 unique IWTK users returned swabs for testing; 3407 (45%) users requested both genital and extragenital tests and were included in this analysis. Descriptive statistics were summarized for demographic characteristics, reported behaviors, and genital and extragenital test results, and data were stratified by gender and age group. A logistic regression model was used to estimate associations between factors and extragenital sexually transmitted infection positivity.
Chlamydia positivity rates were 4.7%, 2.4%, and 1.5% at genital, extragenital, and both sites, respectively; for gonorrhea, 0.4%, 1.1%, and 0.4% were positive at those sites, respectively. Among women, age 25 years and younger was significantly associated with extragenital chlamydia (odds ratio [OR], 4.0; P = 0.010). Being in high-risk quiz score group was associated with extragenital chlamydia (OR, 2.6; P = 0.005) and extragenital gonorrhea in men and women (OR, 8.5; P = 0.005).
Extragenital testing detected additional chlamydia and gonorrhea cases in the IWTK user population that would have been missed by genital-only testing, especially for women younger than 25 years and people reported to be at high risk. |
|---|---|
| AbstractList | The 2021 Centers for Disease Control and Prevention sexually transmitted infection treatment guidelines recommend extragenital testing for gonorrhea and chlamydia in men who have sex with men and for women based on reported behaviors and exposures. The "IWantTheKit (IWTK)" program is a free online platform for specimen self-collection and mail-in for combined chlamydia/gonorrhea testing. We sought to assess the additional diagnostic value of extragenital testing compared with genital testing only for chlamydia/gonorrhea and determine factors associated with a positive extragenital test result among IWTK users.BACKGROUNDThe 2021 Centers for Disease Control and Prevention sexually transmitted infection treatment guidelines recommend extragenital testing for gonorrhea and chlamydia in men who have sex with men and for women based on reported behaviors and exposures. The "IWantTheKit (IWTK)" program is a free online platform for specimen self-collection and mail-in for combined chlamydia/gonorrhea testing. We sought to assess the additional diagnostic value of extragenital testing compared with genital testing only for chlamydia/gonorrhea and determine factors associated with a positive extragenital test result among IWTK users.From August 2013 to January 2022, 7612 unique IWTK users returned swabs for testing; 3407 (45%) users requested both genital and extragenital tests and were included in this analysis. Descriptive statistics were summarized for demographic characteristics, reported behaviors, and genital and extragenital test results, and data were stratified by gender and age group. A logistic regression model was used to estimate associations between factors and extragenital sexually transmitted infection positivity.METHODSFrom August 2013 to January 2022, 7612 unique IWTK users returned swabs for testing; 3407 (45%) users requested both genital and extragenital tests and were included in this analysis. Descriptive statistics were summarized for demographic characteristics, reported behaviors, and genital and extragenital test results, and data were stratified by gender and age group. A logistic regression model was used to estimate associations between factors and extragenital sexually transmitted infection positivity.Chlamydia positivity rates were 4.7%, 2.4%, and 1.5% at genital, extragenital, and both sites, respectively; for gonorrhea, 0.4%, 1.1%, and 0.4% were positive at those sites, respectively. Among women, age 25 years and younger was significantly associated with extragenital chlamydia (odds ratio [OR], 4.0; P = 0.010). Being in high-risk quiz score group was associated with extragenital chlamydia (OR, 2.6; P = 0.005) and extragenital gonorrhea in men and women (OR, 8.5; P = 0.005).RESULTSChlamydia positivity rates were 4.7%, 2.4%, and 1.5% at genital, extragenital, and both sites, respectively; for gonorrhea, 0.4%, 1.1%, and 0.4% were positive at those sites, respectively. Among women, age 25 years and younger was significantly associated with extragenital chlamydia (odds ratio [OR], 4.0; P = 0.010). Being in high-risk quiz score group was associated with extragenital chlamydia (OR, 2.6; P = 0.005) and extragenital gonorrhea in men and women (OR, 8.5; P = 0.005).Extragenital testing detected additional chlamydia and gonorrhea cases in the IWTK user population that would have been missed by genital-only testing, especially for women younger than 25 years and people reported to be at high risk.CONCLUSIONSExtragenital testing detected additional chlamydia and gonorrhea cases in the IWTK user population that would have been missed by genital-only testing, especially for women younger than 25 years and people reported to be at high risk. The 2021 Centers for Disease Control and Prevention sexually transmitted infection treatment guidelines recommend extragenital testing for gonorrhea and chlamydia in men who have sex with men and for women based on reported behaviors and exposures. The "IWantTheKit (IWTK)" program is a free online platform for specimen self-collection and mail-in for combined chlamydia/gonorrhea testing. We sought to assess the additional diagnostic value of extragenital testing compared with genital testing only for chlamydia/gonorrhea and determine factors associated with a positive extragenital test result among IWTK users. From August 2013 to January 2022, 7612 unique IWTK users returned swabs for testing; 3407 (45%) users requested both genital and extragenital tests and were included in this analysis. Descriptive statistics were summarized for demographic characteristics, reported behaviors, and genital and extragenital test results, and data were stratified by gender and age group. A logistic regression model was used to estimate associations between factors and extragenital sexually transmitted infection positivity. Chlamydia positivity rates were 4.7%, 2.4%, and 1.5% at genital, extragenital, and both sites, respectively; for gonorrhea, 0.4%, 1.1%, and 0.4% were positive at those sites, respectively. Among women, age 25 years and younger was significantly associated with extragenital chlamydia (odds ratio [OR], 4.0; P = 0.010). Being in high-risk quiz score group was associated with extragenital chlamydia (OR, 2.6; P = 0.005) and extragenital gonorrhea in men and women (OR, 8.5; P = 0.005). Extragenital testing detected additional chlamydia and gonorrhea cases in the IWTK user population that would have been missed by genital-only testing, especially for women younger than 25 years and people reported to be at high risk. |
| Author | Melendez, Johan H Hamill, Matthew M Silver, Barbara Olthoff, Glen Gaydos, Charlotte A Ruby, Kenneth Yu, Tong Manabe, Yukari C Armington, Gretchen S Greenbaum, Adena |
| Author_xml | – sequence: 1 givenname: Tong surname: Yu fullname: Yu, Tong organization: From the Johns Hopkins School of Medicine – sequence: 2 givenname: Johan H surname: Melendez fullname: Melendez, Johan H organization: From the Johns Hopkins School of Medicine – sequence: 3 givenname: Gretchen S surname: Armington fullname: Armington, Gretchen S organization: From the Johns Hopkins School of Medicine – sequence: 4 givenname: Barbara surname: Silver fullname: Silver, Barbara organization: From the Johns Hopkins School of Medicine – sequence: 5 givenname: Charlotte A surname: Gaydos fullname: Gaydos, Charlotte A organization: From the Johns Hopkins School of Medicine – sequence: 6 givenname: Kenneth surname: Ruby fullname: Ruby, Kenneth organization: Baltimore City Health Department, Sexual Health and Wellness Clinics, Baltimore, MD – sequence: 7 givenname: Glen surname: Olthoff fullname: Olthoff, Glen organization: Baltimore City Health Department, Sexual Health and Wellness Clinics, Baltimore, MD – sequence: 8 givenname: Adena surname: Greenbaum fullname: Greenbaum, Adena organization: Baltimore City Health Department, Sexual Health and Wellness Clinics, Baltimore, MD – sequence: 9 givenname: Matthew M surname: Hamill fullname: Hamill, Matthew M – sequence: 10 givenname: Yukari C surname: Manabe fullname: Manabe, Yukari C organization: From the Johns Hopkins School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36729630$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkF9LwzAUxYNM3B_9BiJhT750Jm2TNI9jTB0OptjpY0nTZEbadCYpbN_eghN2Xu55-HHvuWcMBra1CoBbjGYYcfawWb_N0JkwS5MLMMIkYVFKYjw480Mw9v67Z9IM4SswTCiLOU3QCIh5VakKfoi6U7DVcHkITuyUNUHU8F0dOlHXR5g7YX1jQujRldVKBtNamCsfjN1BY-F09SlsyL_UiwlT-OranRMN3Hrl_DW41KL26uY0J2D7uMwXz9F687RazNeRTBhJIoZ0_wGhrMSM9sFTJkmlqNBMslhRQiXPBI2riqMyQ1xwoYlWJcmk0BmXOp6A-7-9e9f-dH20ojFeqroWVrWdL2LGME_T_kiP3p3QrmxUVeydaYQ7Fv-1xL9i6mb1 |
| ContentType | Journal Article |
| Copyright | Copyright © 2022 American Sexually Transmitted Diseases Association. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2022 American Sexually Transmitted Diseases Association. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/OLQ.0000000000001743 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1537-4521 |
| ExternalDocumentID | 36729630 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: UM1 AI068613 – fundername: NIBIB NIH HHS grantid: U54 EB007958 |
| GroupedDBID | --- -ET ..I .XZ .Z2 01R 0R~ 123 1J1 354 40H 4Q1 4Q2 4Q3 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO AAYEP ABASU ABBUW ABDIG ABHFT ABJNI ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACPRK ACWDW ACWRI ACXJB ACXNZ ACZKN ADGGA ADGHP ADHPY AE6 AEBDS AENEX AFBFQ AFDTB AFEXH AFMBP AFNMH AFRAH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASUFR BKOMP BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIWNM DU5 E.X EBS ECM EEVPB EIF ERAAH EX3 F2M F2N F5P FCALG FL- FRP GNXGY GQDEL H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 L-C L7B LMP NPM N~7 N~B O9- OAG OAH OBH ODMTH OHH OHYEH OK1 OLB OLG OLH OLU OLY OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWV OWW OWZ OXXIT P2P PQQKQ RIG RLZ RXW S4R S4S TAE TEORI TR2 TSPGW V2I VVN W2D W3M WH7 WOQ WOW X3V X3W XFW XYM YFH YOC ZFV ZY1 7X8 ADKSD ADSXY |
| ID | FETCH-LOGICAL-c3753-70f174567b17615347c5de6af7c72e656c98a62dd90b809a9af5feb58caf89cf2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00007435-202303000-00003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1537-4521 |
| IngestDate | Mon Sep 08 13:47:55 EDT 2025 Mon Jul 21 05:40:40 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | Copyright © 2022 American Sexually Transmitted Diseases Association. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3753-70f174567b17615347c5de6af7c72e656c98a62dd90b809a9af5feb58caf89cf2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pmc.ncbi.nlm.nih.gov/articles/PMC10104591/pdf/nihms-1852803.pdf |
| PMID | 36729630 |
| PQID | 2771944174 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2771944174 pubmed_primary_36729630 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-03-01 20230301 |
| PublicationDateYYYYMMDD | 2023-03-01 |
| PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Sexually transmitted diseases |
| PublicationTitleAlternate | Sex Transm Dis |
| PublicationYear | 2023 |
| SSID | ssj0014801 |
| Score | 2.3727386 |
| Snippet | The 2021 Centers for Disease Control and Prevention sexually transmitted infection treatment guidelines recommend extragenital testing for gonorrhea and... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 138 |
| SubjectTerms | Adult Chlamydia Chlamydia Infections - diagnosis Chlamydia Infections - epidemiology Chlamydia Infections - prevention & control Chlamydia trachomatis Female Gonorrhea - diagnosis Gonorrhea - epidemiology Gonorrhea - prevention & control Homosexuality, Male Humans Male Sexual and Gender Minorities Sexually Transmitted Diseases - diagnosis Sexually Transmitted Diseases - epidemiology Sexually Transmitted Diseases - prevention & control |
| Title | Added Value of Extragenital Sexually Transmitted Infection Testing in "IWantTheKit" Program Users |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36729630 https://www.proquest.com/docview/2771944174 |
| Volume | 50 |
| WOSCitedRecordID | wos00007435-202303000-00003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qRbz4ftQXsXhd3O4j2ZykSItFWyu22lvJ5iELdbe2W9F_72Q3pSdBcA-5LYTMZOabzMw3CF0RDnKWhgwvpqFjIgaHu7506lpqDi5Oh7Euhk3QbjcaDlnPPrjNbFnlwiYWhlpmwryRX3uUQrwdAIC-mXw4ZmqUya7aERqrqOIDlDEXkw6XWQRDjVLypRpub6--aJ1j9Prx4amkLrSfAea_g8zC2bS2_7vNHbRlYSZulHqxi1ZUuoc2OjaRvo94AwyOxC98PFc407j5lU_BsqRmhAh-LmiYx9-4cGTvSQ6oFLdt1VaK-4aYI33DSYpr7VeQDKjafZLXcK-s9cID08F5gAatZv_2zrHTFhzhQ8ziUFfDrkNC4zo1KDCgIpSKcE0F9RTAPsEiTjwpmRtHLuOM61CrOIwE1xET2jtEa2mWqmOEY7BaoWDadM0GikjmEaaFG0geS-kSUUWXi8MbgTabFAVPVTafjZbHV0VHpQRGk5J2Y-QTCASI75784e9TtGnmwpfFYmeoouEuq3O0Lj7zZDa9KNQE1m6v8wMxlcY9 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Added+Value+of+Extragenital+Sexually+Transmitted+Infection+Testing+in+%22IWantTheKit%22+Program+Users&rft.jtitle=Sexually+transmitted+diseases&rft.au=Yu%2C+Tong&rft.au=Melendez%2C+Johan+H&rft.au=Armington%2C+Gretchen+S&rft.au=Silver%2C+Barbara&rft.date=2023-03-01&rft.issn=1537-4521&rft.eissn=1537-4521&rft.volume=50&rft.issue=3&rft.spage=138&rft_id=info:doi/10.1097%2FOLQ.0000000000001743&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-4521&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-4521&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-4521&client=summon |